Questions
and ghk-cu: Frequently asked questions
Source-derived answers connected to this topic. Only stored records are displayed.
What If My Study Requires Topical Application to Intact Skin?
Use cosmetic-grade or formulate research-grade with a penetration enhancer. Unformulated GHK-Cu in aqueous solution has poor dermal bioavailability due to its hydrophilic character and molecular charge. Stratum corneum penetration is less than 2% without a lipid carrier or ionophoretic enhancement. Cosmetic-grade formulations include delivery systems (liposomes, nanoemulsions, propylene glycol) that increase local tissue concentration by 3–5× compared to free peptide. If you're running a photoaging study or wound healing model in vivo, the cosmetic version is the appropriate choice.
What If I Need to Store Reconstituted GHK-Cu for More Than a Week?
Aliquot and freeze at −80°C immediately after reconstitution. GHK-Cu in solution at 4°C degrades by approximately 10% per week due to peptide bond hydrolysis and copper dissociation. Freeze-thaw cycles also reduce activity. Each cycle costs you 10–15% potency. Best practice: reconstitute the full vial, divide into single-use aliquots in cryovials, snap-freeze in liquid nitrogen or a dry ice/ethanol bath, and store at −80°C. Thaw one aliquot per experimental day and discard any unused material.
What If I Use Cosmetic-Grade GHK-Cu in a Cell Culture Assay?
Don't. The excipients will confound your results. Glycerin, propylene glycol, and preservatives like phenoxyethanol introduce background cytotoxicity and absorbance interference in colorimetric assays (MTT, WST-1, LDH). If you're measuring cell viability, migration, or proliferation, use research-grade material reconstituted in sterile PBS or cell culture medium. Cosmetic formulations are designed for dermal application, not sterile in vitro conditions. The preservative system alone can suppress fibroblast proliferation at concentrations above 0.3%.
What If I Need to Study Collagen Synthesis Pathways Specifically?
Select GHK-Cu. Its high-affinity binding to LRP1 receptors directly activates TGF-β signaling cascades that regulate SMAD-dependent collagen gene transcription (COL1A1, COL3A1). Studies in fibroblast cultures consistently show GHK-Cu upregulates procollagen synthesis by 30–50% at concentrations of 1–10 μM. AHK-Cu's lower LRP1 engagement produces weaker collagen induction under identical conditions—useful if you want to isolate non-TGF-β collagen pathways, but not ideal if maximizing collagen output is the goal. GHK-Cu also increases tissue inhibitors of metalloproteinases (TIMPs), reducing collagen degradation simultaneously.
What If I'm Formulating a Topical Cosmetic Product for Skin Penetration Research?
Choose AHK-Cu. Franz diffusion cell data across ex vivo human skin shows AHK-Cu achieves 2.8-fold greater dermal accumulation than GHK-Cu after 24 hours without penetration enhancers. The alanine methyl group increases lipophilicity enough to cross the lipid-rich stratum corneum passively—GHK-Cu's hydrophilicity requires delivery vehicles (liposomes, niosomes) or chemical enhancers (propylene glycol, ethanol) to achieve comparable penetration. If your research objective is optimizing transdermal delivery or comparing peptide formulations, AHK-Cu provides a clearer signal with fewer confounding variables introduced by delivery systems.
What If I'm Comparing GHK-Cu to Other Copper Peptides Like AHK-Cu?
Use research-grade versions of both to eliminate formulation bias. AHK CU (Ala-His-Lys-Cu) has a similar mechanism but different receptor affinity and gene expression profile compared to GHK-Cu. If you're running a head-to-head comparison in a collagen synthesis assay or wound closure model, source both peptides as lyophilized powders with equivalent purity and reconstitute under identical conditions. Using research-grade GHK-Cu against cosmetic-grade AHK-Cu invalidates the comparison. The formulation difference becomes a confounding variable you can't control.
What If My Experiment Requires Sustained Peptide Exposure Without Frequent Dosing?
Use AHK-Cu. Its resistance to aminopeptidase cleavage maintains effective concentrations in serum-containing media for 8–10 hours compared to GHK-Cu's 4–6 hours. For multi-day protocols—especially in 3D cell culture, organoid models, or bioreactor systems where media changes disrupt experimental conditions—AHK-Cu reduces dosing frequency by approximately 40%. This minimizes concentration fluctuations that confound dose-response relationships. If your protocol includes protease inhibitors in the culture media, this advantage diminishes, and peptide selection should default to receptor specificity instead.